REUN(Delisted)
Reunion Neuroscience·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About REUN
Reunion Neuroscience Inc.
A Canadian-based company that develops psychedelic therapies to help people heal and heighten engagement with the world
100 King Street West, Suite 3400, 1 First Canadian Place, Toronto, ON M5X 1A4
--
Reunion Neuroscience Inc., was incorporated in Canada on September 30, 2008. Field Trip is an international organization focused on combining operations with strategic investments in all aspects of the psychedelic drug value chain. Field Trip conducts research on plant psychedelics and psychedelic-based molecules for future therapeutic applications for specific mental health indications. Field Trip is building a world-class network of clinics focused on psychedelic drug-assisted therapy. The company focuses on developing digital teletherapy tools. "Travel App" is a mobile software application that provides users with a framework and tools for actively oriented awareness expansion activities, including emotion tracking, personalized music, travel record keeping, guided diary, voice recording, etc.
Company Financials
EPS
REUN has released its 2023 Q4 earnings. EPS was reported at -0.41, versus the expected -0.29, missing expectations. The chart below visualizes how REUN has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
